PBE Holdings List

As of Nov 18, 2024

No.	Symbol	Name	% Weight	Shares
1	UTHR	United Therapeutics Corporation	5.58%	38,376
2	ILMN	Illumina, Inc.	5.42%	102,390
3	AMGN	Amgen Inc.	4.63%	40,994
4	ALNY	Alnylam Pharmaceuticals, Inc.	4.50%	47,823
5	BIIB	Biogen Inc.	4.21%	65,929
6	NBIX	Neurocrine Biosciences, Inc.	4.18%	87,859
7	XNCR	Xencor, Inc.	4.00%	426,532
8	EXEL	Exelixis, Inc.	3.97%	284,130
9	TGTX	TG Therapeutics, Inc.	3.79%	316,343
10	NTRA	Natera, Inc.	3.77%	60,783
11	BMRN	BioMarin Pharmaceutical Inc.	3.71%	148,166
12	MNKD	MannKind Corporation	3.70%	1,358,871
13	INCY	Incyte Corporation	3.47%	111,392
14	REGN	Regeneron Pharmaceuticals, Inc.	3.44%	11,152
15	VCYT	Veracyte, Inc.	3.39%	228,459
16	ACAD	ACADIA Pharmaceuticals Inc.	3.20%	464,173
17	CPRX	Catalyst Pharmaceuticals, Inc.	3.01%	357,142
18	OPK	OPKO Health, Inc.	2.94%	4,430,736
19	VCEL	Vericel Corporation	2.92%	136,496
20	BPMC	Blueprint Medicines Corporation	2.87%	78,491
21	PTGX	Protagonist Therapeutics, Inc.	2.83%	172,991
22	TECH	Bio-Techne Corporation	2.79%	102,926
23	ETR: QIA	Qiagen N.V.	2.64%	158,858
24	BCRX	BioCryst Pharmaceuticals, Inc.	2.54%	888,302
25	RGEN	Repligen Corporation	2.50%	50,062
26	COLL	Collegium Pharmaceutical, Inc.	2.29%	193,458
27	NVAX	Novavax, Inc.	2.08%	655,670
28	CDNA	CareDx, Inc	2.01%	229,895
29	HALO	Halozyme Therapeutics, Inc.	1.99%	115,678
30	MYGN	Myriad Genetics, Inc.	1.64%	265,843
31	AGPXX	Invesco Government & Agency Portfolio	0.01%	14,575
32	-CASH-	Cash/Receivables/Payables	0.00%	5,728

As of Nov 18, 2024